Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Modern Rheumatology|May 22, 2019
The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness methodNobuyuki Yajima, Yasushi Tsujimoto, Shingo Fukuma, et al.
Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.
Modern Rheumatology|November 23, 2013
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) studyNorihiro Nishimoto, Koichi Amano, Yasuhiko Hirabayashi, et al.
Modern Rheumatology|November 23, 2013
Retreatment efficacy and safety of tocilizumab in patients with rheumatoid arthritis in recurrence (RESTORE) studyNorihiro Nishimoto, Koichi Amano, Yasuhiko Hirabayashi, et al.
The Journal of Rheumatology|February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort studyHayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Arthritis Research & Therapy|January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trialMasako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Rheumatology (Oxford, England)|February 18, 2022
Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-centre, randomized controlled trialNaoki Kimura, Takuya Kawahara, Yukari Uemura, et al.
Stem Cell Research & Therapy|June 26, 2019
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34<sup>+</sup> cells using the auto-erasable Sendai virus vectorTakashi Okumura, Yumi Horie, Chen-Yi Lai, et al.
Modern Rheumatology|November 10, 2017
Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC)Kenji Oku, Tatsuya Atsumi, Yuji Akiyama, et al.
Annals of the Rheumatic Diseases|January 15, 2018
Splicing variant of <i>WDFY4</i> augments MDA5 signalling and the risk of clinically amyopathic dermatomyositisYuta Kochi, Yoichiro Kamatani, Yuya Kondo, et al.
Pageof 12